At baseline, miR-29a-5p expression in APP/PS1 mice appeared lower than in WT, but this difference did not reach statistical significance (Fig.
2
—
—
The sentences
Pre-treatment with an LNA-based miR-29a-5p inhibitor prior to miR-29a-5p administration showed a slight trend towards preventing neuronal loss induced by miR-29a-5p alone in both APP/PS1 and WT mice, however, this effect was not statistically significant.